Catalyst Wire Dossier Catalyst Wire Dossier

TMX-101

· Telormedix SA
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TMX-101, covering 2015-02-10 to 2015-02-10. Get the full timeline:

Most recent: Clinical Trial Update: Study With TMX-101 in Patients With Carcinoma In Situ (CIS) Bladder Cancer [Phase 2]

See pricing